NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

From JA "First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma."

The MGMT gene promoter was methylated in 39.6% of patients (n?=?131) and unmethylated in 48.9% (n?=?162), with information not available for 11.5% (n?=?38; the missing data relates to the early patients enrolled a decade ago)

GermanCol,
How many of the unknown MGMT group(n=38) do you think are placebo patients?